Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Status Epilepticus | 18 | 2024 | 139 | 4.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 3 | 2023 | 49 | 1.590 |
Why?
|
| Electrocardiography | 3 | 2024 | 964 | 1.500 |
Why?
|
| Epilepsy | 6 | 2024 | 859 | 1.370 |
Why?
|
| Critical Care | 3 | 2024 | 647 | 1.350 |
Why?
|
| Drug Resistant Epilepsy | 9 | 2024 | 201 | 1.350 |
Why?
|
| Electroencephalography | 8 | 2023 | 860 | 1.300 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 3 | 2017 | 21 | 1.200 |
Why?
|
| Seizures, Febrile | 3 | 2021 | 19 | 1.090 |
Why?
|
| Brain Injuries | 9 | 2023 | 760 | 1.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 3 | 2017 | 56 | 0.920 |
Why?
|
| Epileptic Syndromes | 2 | 2021 | 30 | 0.890 |
Why?
|
| Neurophysiological Monitoring | 1 | 2023 | 37 | 0.870 |
Why?
|
| Brain Diseases | 2 | 2023 | 296 | 0.850 |
Why?
|
| Nervous System Diseases | 2 | 2024 | 371 | 0.790 |
Why?
|
| Neurology | 1 | 2022 | 108 | 0.720 |
Why?
|
| White Matter | 1 | 2022 | 181 | 0.710 |
Why?
|
| Anticonvulsants | 8 | 2023 | 372 | 0.700 |
Why?
|
| Mitochondria | 3 | 2017 | 669 | 0.650 |
Why?
|
| Child | 27 | 2024 | 24108 | 0.590 |
Why?
|
| Hippocampus | 5 | 2022 | 811 | 0.590 |
Why?
|
| Benzodiazepines | 5 | 2023 | 98 | 0.590 |
Why?
|
| Cytokines | 1 | 2023 | 1288 | 0.560 |
Why?
|
| HSP70 Heat-Shock Proteins | 3 | 2005 | 69 | 0.490 |
Why?
|
| Mitochondrial Diseases | 2 | 2007 | 135 | 0.490 |
Why?
|
| Hospitals, Pediatric | 5 | 2022 | 779 | 0.460 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2024 | 457 | 0.450 |
Why?
|
| Neurons | 4 | 2017 | 1922 | 0.450 |
Why?
|
| Time-to-Treatment | 3 | 2020 | 188 | 0.450 |
Why?
|
| Heart Rate | 1 | 2016 | 583 | 0.450 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2018 | 1214 | 0.430 |
Why?
|
| Child, Preschool | 19 | 2024 | 13837 | 0.420 |
Why?
|
| Kainic Acid | 4 | 2020 | 27 | 0.390 |
Why?
|
| Epilepsy, Temporal Lobe | 3 | 2022 | 84 | 0.370 |
Why?
|
| Encephalitis | 2 | 2023 | 111 | 0.360 |
Why?
|
| Retrospective Studies | 13 | 2023 | 15878 | 0.350 |
Why?
|
| Rats | 9 | 2022 | 3658 | 0.350 |
Why?
|
| Seawater | 1 | 2019 | 13 | 0.340 |
Why?
|
| Infant | 16 | 2024 | 12347 | 0.340 |
Why?
|
| Bivalvia | 1 | 2019 | 15 | 0.340 |
Why?
|
| Humans | 34 | 2024 | 122409 | 0.330 |
Why?
|
| Symbiosis | 1 | 2019 | 65 | 0.330 |
Why?
|
| Blotting, Western | 5 | 2017 | 1106 | 0.310 |
Why?
|
| Seizures | 6 | 2023 | 875 | 0.310 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2007 | 2 | 0.300 |
Why?
|
| Glutathione | 2 | 2007 | 198 | 0.270 |
Why?
|
| Mitochondrial Proteins | 1 | 2007 | 238 | 0.260 |
Why?
|
| Chaperonin 60 | 1 | 2006 | 32 | 0.260 |
Why?
|
| Bacteria | 1 | 2019 | 482 | 0.260 |
Why?
|
| Peroxynitrous Acid | 1 | 2005 | 7 | 0.250 |
Why?
|
| Gene Products, tat | 1 | 2005 | 28 | 0.250 |
Why?
|
| Stress, Physiological | 2 | 2006 | 264 | 0.250 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 1247 | 0.240 |
Why?
|
| Pediatrics | 2 | 2024 | 1139 | 0.230 |
Why?
|
| Transduction, Genetic | 1 | 2005 | 298 | 0.230 |
Why?
|
| Glutamic Acid | 1 | 2005 | 200 | 0.230 |
Why?
|
| Autophagy | 1 | 2007 | 391 | 0.230 |
Why?
|
| Male | 24 | 2024 | 59575 | 0.230 |
Why?
|
| Heart | 2 | 2021 | 725 | 0.230 |
Why?
|
| Hospitalization | 3 | 2022 | 1727 | 0.220 |
Why?
|
| Animals | 14 | 2022 | 33891 | 0.210 |
Why?
|
| Monitoring, Physiologic | 2 | 2022 | 355 | 0.210 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2024 | 469 | 0.210 |
Why?
|
| Diet, Ketogenic | 2 | 2021 | 23 | 0.200 |
Why?
|
| Infectious Encephalitis | 1 | 2020 | 4 | 0.190 |
Why?
|
| Circadian Rhythm | 2 | 2020 | 267 | 0.180 |
Why?
|
| Professional Practice Gaps | 1 | 2020 | 15 | 0.180 |
Why?
|
| Adolescent | 11 | 2024 | 18971 | 0.180 |
Why?
|
| Prospective Studies | 5 | 2024 | 5970 | 0.180 |
Why?
|
| Brain | 4 | 2007 | 2947 | 0.180 |
Why?
|
| Photoperiod | 1 | 2019 | 20 | 0.170 |
Why?
|
| Cohort Studies | 4 | 2021 | 4648 | 0.160 |
Why?
|
| Critical Illness | 1 | 2024 | 588 | 0.160 |
Why?
|
| Synapses | 2 | 2022 | 447 | 0.160 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2017 | 42 | 0.160 |
Why?
|
| Receptors, AMPA | 1 | 2018 | 49 | 0.150 |
Why?
|
| Post-Synaptic Density | 1 | 2017 | 11 | 0.150 |
Why?
|
| Synaptotagmin I | 1 | 2017 | 9 | 0.150 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2017 | 9 | 0.150 |
Why?
|
| Guideline Adherence | 1 | 2020 | 376 | 0.150 |
Why?
|
| Emergency Treatment | 1 | 2018 | 86 | 0.150 |
Why?
|
| Poly ADP Ribosylation | 1 | 2017 | 1 | 0.140 |
Why?
|
| Dendritic Spines | 1 | 2017 | 56 | 0.140 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2016 | 12 | 0.140 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2016 | 18 | 0.140 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 4310 | 0.140 |
Why?
|
| Connexin 43 | 1 | 2016 | 30 | 0.140 |
Why?
|
| Disease Progression | 1 | 2023 | 1994 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2017 | 355 | 0.140 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2016 | 57 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 815 | 0.130 |
Why?
|
| Female | 17 | 2024 | 64937 | 0.130 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 145 | 0.130 |
Why?
|
| Antioxidants | 2 | 2009 | 337 | 0.130 |
Why?
|
| Emergency Medical Services | 1 | 2020 | 430 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2016 | 168 | 0.130 |
Why?
|
| Glasgow Coma Scale | 2 | 2006 | 200 | 0.120 |
Why?
|
| Cerebral Cortex | 3 | 2006 | 446 | 0.110 |
Why?
|
| Microscopy, Electron | 2 | 2017 | 401 | 0.110 |
Why?
|
| Child Abuse | 2 | 2005 | 199 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 3455 | 0.090 |
Why?
|
| Time Factors | 3 | 2019 | 6176 | 0.090 |
Why?
|
| Myocardium | 1 | 2016 | 983 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2020 | 1677 | 0.090 |
Why?
|
| Hydrogenase | 1 | 2019 | 1 | 0.090 |
Why?
|
| Mytilidae | 1 | 2019 | 1 | 0.090 |
Why?
|
| Hydrothermal Vents | 1 | 2019 | 1 | 0.090 |
Why?
|
| Biodiversity | 1 | 2019 | 64 | 0.080 |
Why?
|
| Ecosystem | 1 | 2019 | 76 | 0.080 |
Why?
|
| Genetic Heterogeneity | 1 | 2019 | 124 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2023 | 3231 | 0.080 |
Why?
|
| Cytochromes c | 2 | 2005 | 51 | 0.080 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2008 | 22 | 0.080 |
Why?
|
| Subcellular Fractions | 2 | 2005 | 98 | 0.080 |
Why?
|
| Metagenome | 1 | 2019 | 150 | 0.080 |
Why?
|
| Young Adult | 5 | 2020 | 8805 | 0.080 |
Why?
|
| Age Factors | 3 | 2020 | 2779 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 1714 | 0.070 |
Why?
|
| Oxidative Stress | 3 | 2009 | 798 | 0.070 |
Why?
|
| Cell Respiration | 1 | 2007 | 24 | 0.070 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 374 | 0.070 |
Why?
|
| Electron Transport | 1 | 2007 | 54 | 0.070 |
Why?
|
| NAD | 1 | 2007 | 50 | 0.070 |
Why?
|
| Whole-Body Irradiation | 1 | 2007 | 66 | 0.070 |
Why?
|
| Cell Death | 2 | 2005 | 242 | 0.070 |
Why?
|
| Hypothermia, Induced | 1 | 2009 | 158 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2541 | 0.070 |
Why?
|
| Nitrogen | 1 | 2007 | 135 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2006 | 872 | 0.070 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2007 | 244 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2017 | 3076 | 0.060 |
Why?
|
| Lactate Dehydrogenases | 1 | 2005 | 2 | 0.060 |
Why?
|
| Hospital Mortality | 2 | 2021 | 996 | 0.060 |
Why?
|
| Tetrazolium Salts | 1 | 2005 | 15 | 0.060 |
Why?
|
| Cerebrospinal Fluid | 1 | 2005 | 93 | 0.060 |
Why?
|
| Base Sequence | 1 | 2019 | 3119 | 0.060 |
Why?
|
| Thiazoles | 1 | 2005 | 96 | 0.060 |
Why?
|
| Sex Factors | 3 | 2020 | 1234 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2005 | 1007 | 0.060 |
Why?
|
| Microbiota | 1 | 2019 | 392 | 0.060 |
Why?
|
| Asphyxia | 1 | 2004 | 14 | 0.060 |
Why?
|
| Accidents | 1 | 2004 | 15 | 0.060 |
Why?
|
| Florida | 1 | 2024 | 72 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2016 | 4514 | 0.060 |
Why?
|
| Glasgow Outcome Scale | 1 | 2004 | 46 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 900 | 0.060 |
Why?
|
| Central Nervous System Diseases | 1 | 2004 | 105 | 0.060 |
Why?
|
| Diazepam | 1 | 2023 | 21 | 0.050 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2023 | 29 | 0.050 |
Why?
|
| Transcriptome | 1 | 2019 | 906 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 1759 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2005 | 810 | 0.050 |
Why?
|
| Oligodendroglia | 1 | 2023 | 84 | 0.050 |
Why?
|
| Phenotype | 2 | 2023 | 4217 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2003 | 169 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2022 | 117 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 2003 | 194 | 0.050 |
Why?
|
| Midazolam | 1 | 2021 | 49 | 0.050 |
Why?
|
| Apoptosis | 2 | 2005 | 1792 | 0.050 |
Why?
|
| Craniocerebral Trauma | 1 | 2003 | 140 | 0.050 |
Why?
|
| Infant, Newborn | 3 | 2018 | 8113 | 0.050 |
Why?
|
| Cannabidiol | 1 | 2021 | 21 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2006 | 742 | 0.050 |
Why?
|
| Epilepsy, Generalized | 1 | 2021 | 64 | 0.050 |
Why?
|
| Phenobarbital | 1 | 2020 | 36 | 0.040 |
Why?
|
| Immune System Diseases | 1 | 2021 | 45 | 0.040 |
Why?
|
| Syndrome | 1 | 2023 | 1122 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2023 | 420 | 0.040 |
Why?
|
| Phenytoin | 1 | 2020 | 64 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 2077 | 0.040 |
Why?
|
| Biomarkers | 2 | 2006 | 2942 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 1114 | 0.040 |
Why?
|
| Heart Arrest | 1 | 2004 | 341 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2021 | 12036 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2020 | 539 | 0.040 |
Why?
|
| Cerebral Palsy | 1 | 2020 | 79 | 0.040 |
Why?
|
| Fever | 1 | 2021 | 295 | 0.040 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2018 | 129 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2003 | 1023 | 0.040 |
Why?
|
| Mice | 2 | 2020 | 17637 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 420 | 0.040 |
Why?
|
| Presynaptic Terminals | 1 | 2017 | 76 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 1293 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 1403 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 728 | 0.030 |
Why?
|
| Prognosis | 1 | 2006 | 4492 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 607 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2017 | 356 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2021 | 1160 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2019 | 475 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2020 | 694 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 701 | 0.030 |
Why?
|
| Length of Stay | 1 | 2020 | 1272 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2018 | 673 | 0.030 |
Why?
|
| Precipitin Tests | 2 | 2004 | 153 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2017 | 1165 | 0.030 |
Why?
|
| Intellectual Disability | 1 | 2020 | 1043 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2017 | 3780 | 0.020 |
Why?
|
| Caspase 1 | 1 | 2005 | 42 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2005 | 130 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2006 | 145 | 0.020 |
Why?
|
| Caspases | 1 | 2005 | 160 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 325 | 0.010 |
Why?
|
| Y Chromosome | 1 | 2004 | 48 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 261 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2006 | 241 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 153 | 0.010 |
Why?
|
| Chromosomes | 1 | 2004 | 199 | 0.010 |
Why?
|
| Memory Disorders | 1 | 2006 | 235 | 0.010 |
Why?
|
| Spleen | 1 | 2004 | 287 | 0.010 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2003 | 2 | 0.010 |
Why?
|
| Neuronal Plasticity | 1 | 2006 | 274 | 0.010 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 2003 | 6 | 0.010 |
Why?
|
| X Chromosome | 1 | 2004 | 339 | 0.010 |
Why?
|
| United States | 1 | 2018 | 10475 | 0.010 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2004 | 78 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2004 | 255 | 0.010 |
Why?
|
| Proteomics | 1 | 2006 | 478 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2003 | 462 | 0.010 |
Why?
|
| Cell Survival | 1 | 2004 | 816 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 410 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 1301 | 0.010 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2004 | 312 | 0.010 |
Why?
|
| Aging | 1 | 2006 | 1163 | 0.010 |
Why?
|
| DNA | 1 | 2004 | 1608 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2006 | 1934 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 2041 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2003 | 2590 | 0.010 |
Why?
|
| Aged | 1 | 2003 | 18777 | 0.000 |
Why?
|
| Middle Aged | 1 | 2003 | 25586 | 0.000 |
Why?
|
| Adult | 1 | 2003 | 28743 | 0.000 |
Why?
|